Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.63 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | RAD52 | P43351 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL36099 | 1.00 | TSHR (0.63) | TSHRNAAAHCAR2EPHX1RAD52 | |
| SCHEMBL10607704 | 1.00 | TSHR (0.63) | TSHRNAAAHCAR2EPHX1RAD52 | |
| SCHEMBL10607403 | 1.00 | TSHR (0.63) | TSHRNAAAHCAR2EPHX1RAD52 | |
| SCHEMBL1831155 | 1.00 | TSHR (0.63) | TSHRNAAAHCAR2EPHX1RAD52 | |
| SCHEMBL10587093 | 1.00 | TSHR (0.63) | TSHRNAAAHCAR2EPHX1RAD52 | |
| SCHEMBL10602355 | 1.00 | TSHR (0.63) | TSHRNAAAHCAR2EPHX1RAD52 | |
| SCHEMBL10605876 | 1.00 | TSHR (0.63) | TSHRNAAAHCAR2EPHX1RAD52 | |
| SCHEMBL3956877 | 1.00 | TSHR (0.63) | TSHRNAAAHCAR2EPHX1RAD52 | |
| SCHEMBL4147264 | 1.00 | TSHR (0.63) | TSHRNAAAHCAR2EPHX1RAD52 | |
| SCHEMBL5508660 | 1.00 | TSHR (0.63) | TSHRNAAAHCAR2EPHX1RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3609938-B1 | CROSSLINKABLE COMPOSITIONS BASED ON ELECTROACTIVE FLUORINATED COPOLYMERS | ARKEMA FRANCE (FR) | 2026-04-08 | — | — | EP | claimed |
| CN-113454147-B | Crosslinkable electroactive fluorinated polymers comprising photoactive groups | 阿科玛法国公司 | 2024-05-10 | — | — | CN | claimed |
| US-20220411550-A1 | CROSSLINKABLE ELECTROACTIVE FLUOROPOLYMERS COMPRISING PHOTOACTIVE GROUPS | ARKEMA FRANCE (FR) | 2022-12-29 | — | — | US | claimed |
| CN-112390820-B | Composition monomer capable of being cured to form film, composition thereof and application of composition | 吉林奥来德光电材料股份有限公司 | 2022-07-19 | — | — | CN | claimed |
| US-20220098343-A1 | Crosslinkable electroactive fluoropolymers comprising photoactive groups | ARKEMA FRANCE (FR) | 2022-03-31 | — | — | US | claimed |
| EP-3898791-A1 | FLUORINATED ELECTROACTIVE CROSS-LINKABLE POLYMERS COMPRISING PHOTOACTIVE GROUPS | ARKEMA FRANCE (FR) | 2021-10-27 | — | — | EP | claimed |
| EP-3898713-A1 | CROSSLINKABLE ELECTROACTIVE FLUORINATED POLYMERS COMPRISING PHOTOACTIVE GROUPS | ARKEMA FRANCE (FR) | 2021-10-27 | — | — | EP | claimed |
| CN-112390820-A | Composition monomer capable of being cured to form film, composition thereof and application of composition | 吉林奥来德光电材料股份有限公司 | 2021-02-23 | — | — | CN | claimed |
| CN-107747253-B | Superfine cellulose modified material and preparation method thereof | 派恩(中山)科技有限公司 | 2020-09-01 | — | — | CN | claimed |
| WO-2020128264-A1 | FLUORINATED ELECTROACTIVE CROSS-LINKABLE POLYMERS COMPRISING PHOTOACTIVE GROUPS | ARKEMA FRANCE (FR) | 2020-06-25 | — | — | WO | claimed |
| US-8735464-B2 | Radically curable urethane dimethacrylates and compositions thereof for tougher dental prosthetics | PULPDENT CORPORATION (US) | 2014-05-27 | — | — | US | claimed |
| US-20130041067-A1 | Radically Curable Urethane Dimethacrylates and Compositions Thereof for Tougher Dental Prosthetics | PULPDENT CORPORATION (US) | 2013-02-14 | — | — | US | claimed |
| CN-102756548-A | Assisted maintenance for printhead faceplate surface | XEROX CORP | 2012-10-31 | — | — | CN | claimed |
| US-8292625-B2 | Radically curable urethane dimethacrylates and compositions thereof for tougher dental prosthetics | PULPDENT CORPORATION (US) | 2012-10-23 | — | — | US | claimed |
| US-20120021383-A1 | Radically Curable Urethane Dimethacrylates and Compositions Thereof for Tougher Dental Prosthetics | PULPDENT CORPORATION (US) | 2012-01-26 | — | — | US | claimed |
| EP-1925043-B1 | ENCAPSULATED DEVICES AND METHOD OF MAKING | SAMSUNG MOBILE DISPLAY CO LTD (KR) | 2011-05-11 | — | — | EP | claimed |
| US-7767498-B2 | Encapsulated devices and method of making | VITEX SYSTEMS, INC. (US) | 2010-08-03 | — | — | US | claimed |
| EP-1925043-A1 | ENCAPSULATED DEVICES AND METHOD OF MAKING | Vitex Systems Inc. (US) | 2008-05-28 | — | — | EP | claimed |
| US-20070049155-A1 | Encapsulated devices and method of making | VITEX SYSTEMS, INC. (US) | 2007-03-01 | — | — | US | claimed |
| WO-2007025140-A1 | ENCAPSULATED DEVICES AND METHOD OF MAKING | VITEX SYSTEMS, INC. (US) | 2007-03-01 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120021383-A1 | Radically Curable Urethane Dimethacrylates and Compositions Thereof for Tougher Dental Prosthetics | XRCC6, PUF60, ESD | TSHR 4734/4885NAAA 2713/4885HCAR2 3493/4885 |
| US-20130041067-A1 | Radically Curable Urethane Dimethacrylates and Compositions Thereof for Tougher Dental Prosthetics | XRCC6, PUF60, ESD | TSHR 4734/4885NAAA 2713/4885HCAR2 3493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.